NeuroPace (NPCE) Amortization of Deferred Charges (2020 - 2026)
NeuroPace (NPCE) recorded quarterly Amortization of Deferred Charges of $68000.0 in Q1 2026, down 71.31% quarter-over-quarter from $237000.0 in Q4 2025, and up 38.78% on a YoY basis from $49000.0 in Q1 2025.
NeuroPace (NPCE) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
NeuroPace's Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $68000.0 for Q1 2026.
- In Q1 2026, Amortization of Deferred Charges rose 38.78% year-over-year to $68000.0; the TTM figure through Mar 2026 stood at $405000.0 (up 62.65% YoY), while the FY2025 annual figure was $237000.0, down 82.94% from the prior year.
- Amortization of Deferred Charges was $68000.0 for Q1 2026 at NeuroPace, down from $237000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $689000.0 in Q4 2023 to a low of $49000.0 in Q1 2025.
- Historically, Amortization of Deferred Charges has averaged $223214.3 across 5 years, with a median of $100000.0 in 2022.
- The sharpest annual moves came in 2024 and 2026: Amortization of Deferred Charges sank 87.98% in 2024, then jumped 38.78% in 2026.
- A 5-year view of Amortization of Deferred Charges shows it stood at $655000.0 in 2022, then climbed by 5.19% to $689000.0 in 2023, then slumped by 85.49% to $100000.0 in 2024, then soared by 137.0% to $237000.0 in 2025, then plunged by 71.31% to $68000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $68000.0 (Q1 2026), $237000.0 (Q4 2025), and $100000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | NeuroPace | 527.50 Mn | 473.52 Mn | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68,000.00 |
| Mar 31, 2026 | 68,000.00 |
| Dec 31, 2025 | 237,000.00 |
| Dec 31, 2025 | 237,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 78,000.00 |
| Mar 31, 2024 | 78,000.00 |
| Dec 31, 2023 | 689,000.00 |
| Dec 31, 2023 | 689,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |